CIK 1232621
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 77.67% | 46 |
| Unclassified | 16.24% | 4 |
| Health Care Providers & Services | 6.09% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | AUPH | Aurinia Pharmaceuticals Inc. | Health Care | 9.20% |
| 2 | CELC | Celcuity Inc. | Health Care | 6.09% |
| 3 | MIRM | Mirum Pharmaceuticals, Inc. | Health Care | 5.80% |
| 4 | LKFT | GALAPAGOS NV | Unclassified | 5.77% |
| 5 | SPY | STATE STR SPDR S&P 500 ETF T | Unclassified | 5.55% |
| 6 | KNSA | Kiniksa Pharmaceuticals International, plc | Health Care | 5.53% |
| 7 | CAPR | CAPRICOR THERAPEUTICS, INC. | Health Care | 5.25% |
| 8 | PTCT | PTC THERAPEUTICS, INC. | Health Care | 5.19% |
| 9 | SYRE | Spyre Therapeutics, Inc. | Health Care | 4.85% |
| 10 | KALVISTA PHARMACEUTICALS INC | Unclassified | 4.68% |
47/51 names classified · sector 83.8% of weight · industry 83.8% · mkt cap 81.6%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 83.8% of the book is sector-classified (unclassified names shown, never dropped).
Only 26% of book weight classified — the grid is NOT representative of the whole book.
Classified: 26.3% of book weight (8/50 names) · unclassified 73.7%: CELC, MIRM, LKFT, SPY, CAPR, , SYRE, CMPX, TARS, IMCR +32 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | AUPHAURINIA PHARMACEUTICALS INC | 12,229,500 | $181M | 9.2% | ADD 8% |
| 2 | CELCCELCUITY INC | 1,050,000 | $120M | 6.1% | HOLD |
| 3 | MIRMMIRUM PHARMACEUTICALS INC | 1,236,027 | $114M | 5.8% | HOLD |
| 4 | LKFTGALAPAGOS NV | 3,785,991 | $114M | 5.8% | TRIM −3% |
| 5 | SPYSTATE STR SPDR S&P 500 ETF T | 168,000 | $109M | 5.5% | ADD 460% |
| 6 | KNSAKINIKSA PHARMACEUTICALS INTL | 2,259,889 | $109M | 5.5% | HOLD |
| 7 | CAPRCAPRICOR THERAPEUTICS INC | 3,399,900 | $103M | 5.2% | ADD 100% |
| 8 | PTCTPTC THERAPEUTICS INC | 1,500,000 | $102M | 5.2% | HOLD |
| 9 | SYRESPYRE THERAPEUTICS INC | 1,892,200 | $95M | 4.8% | HOLD |
| 10 | KALVISTA PHARMACEUTICALS INC | 4,573,530 | $92M | 4.7% | HOLD |
| 11 | CMPXCOMPASS THERAPEUTICS INC | 16,790,809 | $89M | 4.5% | HOLD |
| 12 | TARSTARSUS PHARMACEUTICALS INC | 1,188,624 | $83M | 4.2% | HOLD |
| 13 | IMCRIMMUNOCORE HLDGS PLC | 2,649,368 | $80M | 4.1% | HOLD |
| 14 | ANABANAPTYSBIO INC | 1,330,879 | $74M | 3.7% | HOLD |
| 15 | CORTCORCEPT THERAPEUTICS INC | 1,500,000 | $60M | 3.1% | ADD 857% |
| 16 | ANIPANI PHARMACEUTICALS INC | 707,500 | $54M | 2.8% | ADD 47% |
| 17 | INSMINSMED INC | 260,000 | $43M | 2.2% | ADD 333% |
| 18 | BNTXBIONTECH SE | 470,000 | $42M | 2.1% | HOLD |
| 19 | VRDNVIRIDIAN THERAPEUTICS INC | 1,792,626 | $35M | 1.8% | HOLD |
| 20 | AVIRATEA PHARMACEUTICALS INC | 4,814,700 | $26M | 1.3% | HOLD |
| 21 | PGENPRECIGEN INC | 6,417,500 | $25M | 1.3% | ADD 14% |
| 22 | DNTHDIANTHUS THERAPEUTICS INC | 264,692 | $22M | 1.1% | HOLD |
| 23 | CMPSCOMPASS PATHWAYS PLC | 4,002,200 | $22M | 1.1% | NEW |
| 24 | CBIOCRESCENT BIOPHARMA INC. | 1,160,000 | $21M | 1.1% | ADD 33% |
| 25 | STOKSTOKE THERAPEUTICS INC | 500,000 | $16M | 0.8% | HOLD |
| 26 | VKTXVIKING THERAPEUTICS INC | 500,000 | $16M | 0.8% | HOLD |
| 27 | IDYAIDEAYA BIOSCIENCES INC | 450,000 | $15M | 0.8% | HOLD |
| 28 | NUVBNUVATION BIO INC | 3,149,557 | $14M | 0.7% | TRIM −18% |
| 29 | PLRXPLIANT THERAPEUTICS INC | 6,143,132 | $8M | 0.4% | HOLD |
| 30 | DERMJOURNEY MED CORP | 1,610,000 | $8M | 0.4% | TRIM −13% |
| 31 | JANXJANUX THERAPEUTICS INC | 500,000 | $7M | 0.4% | NEW |
| 32 | BIIBBIOGEN INC | 35,000 | $6M | 0.3% | HOLD |
| 33 | URGNUROGEN PHARMA LTD | 350,000 | $6M | 0.3% | HOLD |
| 34 | ARVNARVINAS INC | 538,658 | $6M | 0.3% | TRIM −5% |
| 35 | PMVPPMV PHARMACEUTICALS INC | 4,245,085 | $5M | 0.3% | TRIM −14% |
| 36 | MRNAMODERNA INC | 100,000 | $5M | 0.3% | TRIM −86% |
| 37 | HRTXHERON THERAPEUTICS INC | 6,250,000 | $5M | 0.3% | HOLD |
| 38 | KEZAR LIFE SCIENCES INC | 664,314 | $5M | 0.3% | HOLD |
| 39 | WVEWAVE LIFE SCIENCES LTD | 600,000 | $4M | 0.2% | HOLD |
| 40 | LENZLENZ THERAPEUTICS INC | 451,114 | $4M | 0.2% | TRIM −48% |
| 41 | AGIOAGIOS PHARMACEUTICALS INC | 100,000 | $3M | 0.2% | NEW |
| 42 | ERASERASCA INC | 200,000 | $3M | 0.2% | TRIM −78% |
| 43 | CHRSCOHERUS ONCOLOGY INC | 1,886,748 | $3M | 0.2% | TRIM −31% |
| 44 | NKTXNKARTA INC | 1,480,823 | $3M | 0.2% | HOLD |
| 45 | ALTALTIMMUNE INC | 666,022 | $2M | 0.1% | TRIM −69% |
| 46 | EOLSEVOLUS INC | 483,021 | $2M | 0.1% | TRIM −61% |
| 47 | ABEOABEONA THERAPEUTICS INC | 400,000 | $2M | 0.1% | TRIM −60% |
| 48 | FATEFATE THERAPEUTICS INC | 1,167,773 | $1M | 0.1% | HOLD |
| 49 | NMRANEUMORA THERAPEUTICS INC. | 439,878 | $857,762 | 0.0% | TRIM −55% |
| 50 | LXRXLEXICON PHARMACEUTICALS INC | 399,700 | $623,532 | 0.0% | NEW |
| 51 | RCKTROCKET PHARMACEUTICALS INC | 100,000 | $358,000 | 0.0% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| AUPHAURINIA PHARMACEUTICALS INC | 8.4M | 10.0M | 10.0M | 11.3M | 11.3M | 12.2M | $181M |
| CELCCELCUITY INC | — | — | — | 1.1M | 1.1M | 1.1M | $120M |
| MIRMMIRUM PHARMACEUTICALS INC | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | $114M |
| LKFTGALAPAGOS NV | 2.2M | 4.0M | 4.0M | 4.2M | 3.9M | 3.8M | $114M |
| SPYSTATE STR SPDR S&P 500 ETF T | — | — | — | — | 30K | 168K | $109M |
| KNSAKINIKSA PHARMACEUTICALS INTL | 629K | 2.1M | 2.3M | 2.3M | 2.3M | 2.3M | $109M |
| CAPRCAPRICOR THERAPEUTICS INC | — | 79K | — | — | 1.7M | 3.4M | $103M |
| PTCTPTC THERAPEUTICS INC | 700K | 1.0M | 1.1M | 1.5M | 1.5M | 1.5M | $102M |
| SYRESPYRE THERAPEUTICS INC | — | 2.0M | 3.2M | 3.2M | 1.9M | 1.9M | $95M |
| KALVISTA PHARMACEUTICALS INC | 4.9M | 4.9M | 4.9M | 5.0M | 4.6M | 4.6M | $92M |
| CMPXCOMPASS THERAPEUTICS INC | 5.9M | 11.1M | 13.5M | 16.8M | 16.8M | 16.8M | $89M |
| TARSTARSUS PHARMACEUTICALS INC | 2.3M | 2.5M | 2.5M | 2.5M | 1.2M | 1.2M | $83M |
| IMCRIMMUNOCORE HLDGS PLC | 1.6M | 1.9M | 2.1M | 2.3M | 2.6M | 2.6M | $80M |
| ANABANAPTYSBIO INC | 1.3M | 1.5M | 1.3M | 1.3M | 1.3M | 1.3M | $74M |
| CORTCORCEPT THERAPEUTICS INC | — | — | — | — | 157K | 1.5M | $60M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
